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Abstract
Infections are one of the main causes of mortality in elderly due to the decrease of immune response, for which copper (Cu) 
and zinc (Zn) are claimed to be crucial. High serum copper-to-zinc-ratio (Cu/Zn-ratio) has been reported with infections, 
but little is known whether it could also predict the incidence of infections. The study cohort consisted of 1975 men aged 
42–60 years and free of severe infectious disease at baseline in 1984–1989 from the prospective population-based Kuopio 
Ischaemic Heart Disease Risk Factor Study. The main outcome was an incident infection leading to hospitalization. Cox 
proportional hazards regression models were used for statistical analysis. During the average follow-up of 19.2 years, 636 
incident first cases of infections were diagnosed. The hazard ratio (HR) of developing an incident infectious disease in the 
highest compared to the lowest Cu/Zn-ratio quartile after adjustment for age and baseline examination year was 1.35 [95% 
confidence interval (CI) = 1.07–1.69, P-trend across quartiles = 0.005]. The association was slightly attenuated after addi-
tional adjustment for potential confounders (HR = 1.21, 95% CI = 0.96–1.53, P-trend = 0.054). Furthermore, higher serum 
Cu concentration was associated with higher risk of an incident infection. The multivariable-adjusted HR was 1.39 (95% 
CI = 1.10–1.75, P-trend = 0.005) in the highest versus the lowest serum Cu quartile. Serum Zn concentration was not associ-
ated with the risk (multivariable-adjusted extreme-quartile HR = 0.83, 95% CI = 0.67–1.04, P-trend = 0.218). In conclusion, 
our data suggest that an increased Cu/Zn-ratio and especially serum Cu concentration are associated with increased risk of 
incident infections in middle-aged and older men in Eastern Finland.
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Introduction
Due to the rapidly increasing life expectancy in developed 
countries, the number of elderly people is rising [1]. Elderly 
are more susceptible to infections and more often prone to 
severe complications than the younger individuals [2]. In the 
population of 65 years and older, infections are responsible 
not only for one-third of deaths [3] but also for many inpa-
tient stays [4]. One of the major factors for the higher sus-
ceptibility to infections is the age-related weakening of the 
immune system (immunosenescence) [5].
Copper (Cu) and zinc (Zn) are essential micronutrients 
and crucial components for the development and mainte-
nance of the immune and antioxidative defense system. 
Cu and Zn have an impact especially on the cell-mediated 
immune reactions of both innate and acquired immune 
defense [6, 7]. Earlier studies have shown that deficiencies 
of Cu and Zn predispose to infections, but also systemic 
inflammation and infections induce reduction of serum Zn 
concentration during the acute phase response due to the 
redistribution of the serum Zn into the liver and other tis-
sues [7]. Furthermore, acute infections lead to an increase 
of serum Cu concentration [8]. Both responses result in an 
increased serum Cu/Zn-ratio.
Apart from a clear deficiency or supplementation, the 
serum concentrations of Zn and Cu are not significantly 
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affected by dietary intakes, but are rather a result of patho-
physiological changes in the body [9, 10]. It has been pro-
posed that serum Cu/Zn-ratio would be a superior prog-
nostic and predictive marker for several pathological and 
pre-pathological stages, as it reflects the reciprocal reaction 
of Cu and Zn better than serum Cu or Zn concentrations 
alone [9]. High serum Cu/Zn-ratio is claimed to be associ-
ated with higher risk of cardiovascular mortality [11, 12], 
different cancers [13, 14], and all-cause mortality [15]. A 
higher plasma Cu/Zn-ratio was discovered among hospital-
ized people aged 70 or older than in their healthy controls 
[16]. Furthermore, it was found that Cu/Zn-ratio signifi-
cantly increases with aging, as Zn concentration decreases 
and Cu concentration increases with advancing age [17]. A 
mild Zn deficiency has been claimed to be quite prevalent in 
the elderly population even in developed countries [5, 18]. 
Similarly, decreased serum Zn concentration and increased 
Cu/Zn-ratio has been observed due to a chronic exposure to 
cadmium especially in smokers [19].
Furthermore, little is known whether the serum Cu/Zn-
ratio could have an impact on the risk of getting an infection. 
Therefore, we investigated the relation of serum Cu/Zn-ratio 
with the risk of incident infections in a long-term prospec-
tive cohort study in middle-aged and older Finnish men.
Materials and methods
Study population
The Kuopio ischaemic heart disease risk factor (KIHD) 
Study was designed to investigate risk factors for cardio-
vascular disease, atherosclerosis, and related outcomes in a 
population-based sample of men from eastern Finland [20]. 
The baseline examinations were carried out in 1984–1989. 
A total of 2682 men who were 42, 48, 54, or 60 years old at 
baseline (83% of those eligible) were recruited in 2 cohorts. 
The first cohort consisted of 1166 men who were 54 years 
old and enrolled in 1984–1986, and the second cohort 
included 1516 men who were 42, 48, 54, or 60 years old 
and enrolled in 1986–1989. The baseline characteristics of 
the entire study population were described previously [20].
Data on serum Cu and Zn were available for 2573 men. 
Participants who had the serum CRP > 10 mg/L (n = 68), 
or those with a diagnosis of chronic diseases that are asso-
ciated with increased risk of infections, such as chronic 
bronchitis (n = 195), lung tuberculosis (n = 87), bronchial 
asthma (n = 61), liver or pancreas disease (n = 30) or kid-
ney stones (n = 122), chronic prostatitis (n = 2), thyroid 
therapy (n = 17), or rheumatoid arthritis (n = 16) at entry, 
were excluded, leaving 1975 men for the analysis. In the 
sensitivity analyses, we further excluded men with poten-
tially increased risk of infections, including men with 
history of ischaemic heart disease, stroke, cancer or dia-
betes (n = 551), leaving 1424 men for these analyses.
Data collection
Fasting venous blood samples were drawn between 08.00 
and 10.00 at baseline. Subjects were instructed to abstain 
from ingesting alcohol for 3 days and from smoking and 
eating for 12 h before providing the sample. Copper-free 
needles and tubes were used for collecting and storing the 
blood samples. The subjects rested in a supine position for 
30 min before blood sampling. A tourniquet was not used.
Detailed descriptions of the assessment of medical his-
tory and medications [21], family history of diseases [21], 
smoking [21], alcohol consumption [21], serum ferritin 
[21], and physical activity [22], at baseline have been pub-
lished. Education and annual income were obtained from 
a self-administered questionnaire. BMI was computed as 
the ratio of weight in kilograms to the square of height 
in meters. Dietary intakes at baseline were assessed with 
4-day food records [23]. Serum Cu and Zn concentrations 
were determined by atomic absorption spectrometry from 
frozen samples stored at − 20 °C for 1–5 years prior to 
analyses. Serum zinc concentrations were determined 
in the same batches with copper, method for which has 
been described before [24]. The PerkinElmer 306 atomic 
absorption spectrophotometer (Norwalk, Connecticut, 
USA) was used for measurements (Seronorm Nycomed, 
Oslo, Norway). Control serum samples were included in 
all daily batches. The reference standards were dissolved 
in 5% glycerol. The between-batch coefficient of varia-
tion was 4.0%. An immunometric assay (Immulite High 
Sensitivity C-reactive Protein Assay; DPC, Los Angeles, 
USA) was used to measure serum high-sensitivity CRP.
Ascertainment of follow‑up events
Follow-up diagnoses until 31 December 2012 were col-
lected by record linkage to the national hospital discharge 
register using the Finnish personal identification code. 
International Classification of Diseases (ICD)-8 codes 
002, 003, 008, 009, 035, 038, 053, 057, 060, 070, 078, 
079, 380, 381, 420, 421, 460, 461, 465, 466, 472, 473, 
480, 482, 485, 486, 590, 595, 601, 604, 680–682 and ICD-
10 codes A04, A07–A09, A32, A40, A41, A46, A49, A69, 
A98, B00, B02, B24, B25, B34, B99, G03, H60, I33, I40, 
J01, J06, J13, J15, J18, J20–J22, L02, L03, L30, M00, 
M01, N10, N30, N39, N41and N45 were used to indicate 
an infection. Only the first incident event diagnosis was 
counted.
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Statistical analysis
The distributions of the baseline characteristics in quartiles 
of serum Cu/Zn-ratio were presented as means [± standard 
deviations (SD)] or percentages. The associations between 
serum Cu/Zn-ratio and baseline characteristics were ana-
lysed by using Chi square tests (for categorical variables) 
and by linear regression (for continuous variables).
Multivariable-adjusted Cox proportional hazards regres-
sion models were used to estimate the hazard ratios in quar-
tiles of baseline serum Cu/Zn-ratio and in quartiles of Cu 
and Zn concentrations. Participants contributed follow-up 
time until the first diagnosis of incident infectious dis-
ease, death or the end of follow-up, which ever came first. 
The confounders were selected on the basis of risk factors 
for infections. Model 1 included age (years) and baseline 
examination year. Model 2 included model 1 plus history 
of ischemic heart disease, stroke, cancer or diabetes (yes/
no); smoking (never smoker, previous smoker, current 
smoker < 20 cigarettes/day, current smoker ≥ 20 cigarettes/
day); education (years); income (euros/year); intake of alco-
hol (g/week); leisure-time physical activity (kcal/day); and 
BMI (kg/m2). The cohort mean was used to replace miss-
ing values (< 2.3%). Potential nonlinear associations were 
assessed semiparametrically using restricted cubic splines. 
Statistical significance of the interactions with serum albu-
min and BMI medians and with smoking status (current 
smokers vs. others) on a multiplicative scale was assessed 
by likelihood ratio tests using a cross-product term with 
Cu/Zn-ratio and Cu and Zn concentrations as continuous 
variables. Similar analyses were conducted by stratifying 
the analyses with serum Cu concentration by the median of 
serum Zn concentration and vice versa. Statistical analyses 
were performed using SPSS software version 25 for Macin-
tosh (Armonk, NY, IBM Corp.) and Stata 14.1 (Stata Corp., 
College Station, TX; for spline analysis). All P-values were 
two-sided.
Results
The mean age of the 1975 men was 52.8 years and the mean 
serum Cu/Zn-ratio was 1.2 (SD 0.2, range 0.6–3.0). The 
mean serum Cu and Zn concentrations were 17.4 μmol/L 
(SD 2.7 μmol/L, range 7.2–36.5 μmol/L) and 14.4 μmol/L 
(SD 1.8 μmol/L, range 8.3–24.8 μmol/L), respectively. The 
baseline characteristics of the cohort members according 
to the quartiles of serum Cu/Zn-ratio are shown in Table 1. 
Men with a higher serum Cu/Zn-ratio were more likely to 
be older, be current smokers, consume more alcohol, be less 
educated and have a lower income than men with a lower 
serum Cu/Zn-ratio. Additionally, men with a higher Cu/Zn-
ratio were more likely to have a higher serum C-reactive 
protein concentration and a lower serum albumin concen-
tration. Among dietary factors, men with a higher serum 
Cu/Zn-ratio had higher intake of fish and butter and lower 
intakes of vegetable margarines and oils, grains and fruits, 
berries, vegetables and roots. There was no appreciable dif-
ference in Zn intake between the groups. We did not have 
information on Cu intake.
During the average follow-up time of 19.2 years (SD: 
8.0 years; minimum–maximum 0.1–28.7 years), 636 first 
infections requiring hospitalization occurred. Of these, 171 
(26.9%) were pneumonia, 81 (12.7%) were erysipelas and 
34 (5.3%) were acute bronchitis. After adjustment for age 
and baseline examination year, those in the highest versus 
the lowest Cu/Zn-ratio had 35% higher risk of an incident 
infection (95% CI = 7–69%; P-trend across quartiles 0.005) 
(Table 2, model 1). The association was attenuated after 
further multivariate adjustments for potential confounders 
but the trend towards higher risk remained borderline sta-
tistically significant (P-trend = 0.054) (Table 2, model 2). 
There was no evidence for non-linearity (Fig. 1). Further 
adjustment for serum albumin as a potential marker for poor 
nutritional status had no impact on the associations (data 
not shown).
In the analysis with serum Cu and Zn concentrations 
separately, higher serum Cu concentration was associated 
with higher risk of an incident infection. In the multivaria-
ble-adjusted model (Table 2, model 2), those in the highest 
versus the lowest serum Cu quartile had 39% higher risk of 
an incident infection (95% CI = 10–75%; P-trend = 0.005), 
without evidence for non-linearity (Fig. 1). No statistically 
significant associations were observed with serum Zn con-
centration (Table 2, Fig. 1).
In the sensitivity analysis, we evaluated the associations 
of Cu/Zn-ratio and serum Cu and Zn concentrations with the 
incidence of an infection during the first 10 years of follow-up, 
because the associations with a single measurement at base-
line may be attenuated with a long follow-up period. After 
adjustment for potential confounders (Model 2), men in the 
highest versus the lowest Cu/Zn-ratio had 43% higher risk 
of an incident infection (202 events) (95% CI = 0.95–116%; 
P-trend = 0.043) (Supplementary table). Those in the highest 
versus the lowest serum Cu quartile had 50% higher risk (95% 
CI = 0.98–130%; P-trend = 0.062) (Model 2, Supplementary 
table). In these analyses also serum Zn concentration was 
associated with the risk of an incident infection, with 35% 
lower risk in the highest compared to the lowest quartile (95% 
CI = 4–55%). However, although the P value for trend across 
the quartiles was statistically significant (P-trend = 0.035), the 
lower risk was observed already in the second quartile and 
the risk did not decrease further with increasing serum Zn 
concentration (Supplementary table). Because the serum con-
centrations of both Cu and Zn are affected by the acute phase 
response, we also analysed the associations after excluding the 
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infections that occurred during the first two years of follow-up 
(n = 37). This had only little impact on the associations: the 
HR (95% CI) in the highest versus the lowest quartile was 
1.16 (0.94–1.50, P-trend = 0.06) for the Cu/Zn-ratio, 1.40 
(1.10–1.78, P-trend = 0.005) for Cu and 0.89 (0.71–1.11, 
P-trend = 0.47) for Zn. If the analyses were restricted to the 
men without history of ischemic heart disease, stroke, cancer 
or diabetes (n = 1424, 434 incident infections), the association 
with Cu/Zn-ratio was attenuated (Model 2, extreme-quartile 
HR = 1.22, 95% CI = 0.91–1.63; P-trend = 0.24), but the asso-
ciation with Cu was stronger (extreme-quartile HR = 1.50, 95% 
CI = 1.14–1.99; P-trend = 0.01). There was no statistically sig-
nificant association between serum Zn and incident infections 
in these analyses, either (extreme-quartile HR = 0.88, 95% 
CI = 0.67–1.16; P-trend = 0.57). Finally, we evaluated whether 
serum albumin concentration, BMI or smoking would modify 
the associations. The only statistically significant interaction 
was observed between BMI and serum Zn concentration. 
Serum Zn concentration was associated with a lower risk 
among men with BMI above the median (BMI > 26.4 kg/m2, 
Model 2 extreme-quartile HR = 0.70, 95% CI = 0.52–0.94; 
P-trend = 0.08), but no association was observed among the 
men with BMI below the median (extreme-quartile HR = 1.03, 
95% CI 0.73–1.45; P-trend = 0.92) (P-interaction = 0.049). All 
other interactions were statistically non-significant (P-interac-
tions > 0.15). Neither did we find evidence that the association 
of serum Cu with risk of an incident infection would be modi-
fied by serum Zn concentrations (P-interaction = 0.33) or vice 
versa (P-interaction = 0.49).
Discussion
In this prospective, population-based cohort study, we 
found that a higher Cu/Zn-ratio and a higher concentra-
tion of serum Cu were associated with a higher risk of an 
Table 1  Baseline characteristics of 1975 KIHD participants by quartiles of serum Cu/Zn-ratio
a P-trend was calculated by using linear regression (continuous variables) or by Chi square test (categorical variables)
b Values are means (SD) or percentages
c Includes red meat, white meat, game and offal
d Values adjusted for total energy intake using the residual method
Characteristic Serum Cu/Zn-ratio quartile P-trenda
1 (0.59–1.03) 2 (1.04–1.17) 3 (1.18–1.33) 4 (1.34–2.97)
Participants, n 494 493 495 493
Age, years 52.0 (5.5)b 52.6 (5.2) 52.8 (5.1) 53.7 (5.0) < 0.001
Body mass index, kg/m2 26.7 (3.3) 27.0 (3.7) 26.8 (3.4) 26.8 (3.7) 0.990
Leisure time physical activity, kcal/day 135 (151) 155 (177) 139 (171) 128 (170) 0.235
Education, years 9.4 (4.0) 8.7 (3.5) 8.6 (3.3) 8.2 (3.1) < 0.001
Income, Euros/year 14 745 (9937) 13 933 (9514) 13 427 (7910) 12 300 (9004) < 0.001
Alcohol intake, g/week 56 (103) 57 (86) 72 (107) 108 (157) < 0.001
Current smoker, % 21 24 30 41 < 0.001
Multivitamin use, % 2.0 1.0 0.2 1.0 0.049
History of ischemic heart disease, stroke, 
cancer or diabetes, %
24 28 28 33 0.003
Serum C-reactive protein, mg/L 1.2 (1.1) 1.5 (1.4) 1.8 (1.6) 2.7 (2.3) < 0.001
Serum ferritin, nmol/L 0.4 (0.3) 0.4 (0.3) 0.4 (0.4) 0.4 (0.3) 0.242
Serum albumin, g/L 43.2 (3.4) 42.8 (3.5) 42.1 (3.6) 41.6 (3.5) < 0.001
Dietary intakes
 Energy intake, kcal/day 2455 (588) 2486 (585) 2423 (620) 2405 (656) 0.083
 Meat g/dc 160 (88) 158 (76) 157 (80) 161 (76) 0.916
 Dairy g/d 709 (362) 723 (350) 711 (361) 702 (367) 0.660
 Fish g/d 40 (48) 44 (52) 46 (51) 52 (59) < 0.001
 Eggs, g/d 34 (26) 33 (26) 32 (24) 31 (26) 0.074
 Grains, g/d 262 (93) 266 (93) 252 (92) 241 (95) < 0.001
 Vegetable margarines and oils, g/d 22 (18) 20 (17) 19 (16) 17 (15) < 0.001
 Butter, g/d 29 (25) 34 (27) 32 (25) 36 (29) 0.002
 Fruits, berries, vegetables, roots, g/d 437 (175) 433 (174) 418 (193) 386 (165) < 0.001
 Zinc, mg/dd 15 (4) 15 (3) 15 (3) 15 (3) 0.302
1153Serum copper-to-zinc-ratio and risk of incident infection in men: the Kuopio Ischaemic Heart…
1 3
incident infection requiring hospitalization, in middle-aged 
and older men from Eastern Finland. Serum Zn concentra-
tion was associated with the risk only in the analysis with 
a shorter follow-up of 10 years but not in the analyses with 
the full follow-up of an average 19 years. To our knowledge, 
the present study is the first to report on the relation between 
Cu/Zn-ratio and infection incidence in a population-based 
setting.
The observation of the higher risk with higher Cu/Zn-
ratio may have various reasons. For the proper functioning 
of the innate and adapted immune response both of these 
micronutrients and their reciprocal relation are essential 
[25]. The optimum of the serum Cu/Zn-ratio lies between 
0.7 and 1.0 [25], and also in our study the risk started to 
increase after the ratio exceeded 1.0 (Fig. 1). An increased 
serum Cu/Zn-ratio has been suggested as a valuable clini-
cal marker in several case–control studies with bacterial, 
viral and parasitic infections [26–28], and in cohort stud-
ies with risk of all-cause, cancer, cardiovascular or HIV-1 
mortality [11, 12, 15, 29]. Elderly are more susceptible to 
infections than younger people, and infections are an impor-
tant cause not only for morbidity and mortality but also for 
hospital-admissions in elderly individuals [30]. Partly, this 
is due to the age-related weakening of the immune system 
(immunosenescence) [31]. Both Cu and Zn participate in 
antioxidant stress modulation [32, 33], and Cu/Zn-ratio had 
been used as a marker of oxidative stress burden [34]. A 
higher Cu/Zn-ratio may thus reflect an elevated oxidative 
stress burden, which may boost the age-related weakening 
of the immune system and contribute to the susceptibility 
to infections during ageing. Furthermore, it has been sug-
gested that the increase of the serum Cu/Zn-ratio seems to 
be a frequent phenomenon related to age, chronic diseases 
and their pathological changes [9].
It has been suggested that the serum Cu/Zn-ratio is a 
superior marker of events to either serum Cu or Zn con-
centration separately [35]. However, in the present study 
serum Cu concentration had a stronger association with 
incidence of an infection than the serum Cu/Zn-ratio. The 
mean Cu concentration of the subjects in this study (17.4 
μmol/L) corresponds well to the mean Cu concentrations 
for men obtained in studies in several European countries 
[36]. Of the subjects, 4.5% have higher Cu concentration 
than the upper reference value of Cu (22.0 μmol/L). The 
concentration of serum Cu is typically elevated in inflam-
mation and infections [8], but the specific reasons for this 
phenomenon are still not clarified in detail [29]. The high 
concentration of serum Cu corresponds to the elevation of 
ceruloplasmin in serum. Ceruloplasmin is elevated in acute 
phase response [37]. As ceruloplasmin plays an important 
role in iron metabolism, it has been proposed that the high 
serum concentration of ceruloplasmin could rather reflect 
Table 2  Risk of an incident 
infection according to the 
quartiles of serum Cu/Zn-ratio 
and Cu and Zn concentration
a Values are hazard ratio (95% confidence interval)
IR incidence rate, PY person-years
Model 1: adjusted for age and examination year
Model 2: adjusted for model 1 and history of coronary heart disease, stroke, cancer or diabetes (yes/no); 
smoking (never smoker, previous smoker, current smoker < 20 cigarettes/day, current smoker ≥ 20 ciga-
rettes/day); education (years); income (euros/year); intake of alcohol (g/week); leisure-time physical activ-
ity (kcal/day); and body mass index
Serum parameter Quartile of serum parameter P-trend
1 2 3 4
Serum Cu/Zn-ratio 0.59–1.03 1.04–1.17 1.18–1.33 1.34–2.97
N of events/subjects 140/494 (28.3%) 157/493 (31.8%) 174/495 (35.2%) 165/493 (33.5%)
IR/1000 PY 13.8 16.0 18.4 19.0
Model 1 1 1.14 (0.91–1.43)a 1.33 (1.06–1.66) 1.35 (1.07–1.69) 0.005
Model 2 1 1.08 (0.86–1.36) 1.28 (1.02–1.60) 1.21 (0.96–1.53) 0.054
Serum Cu (μmol/L) 7.24–15.58 15.59–17.31 17.32–18.88 18.89–36.51
N of events/subjects 124/453 (27.4%) 182/573 (31.8%) 156/475 (32.8%) 174/474 (36.7%)
IR/1000 PY 13.2 15.9 17.6 20.7
Model 1 1 1.17 (0.93–1.48) 1.30 (1.03–1.65) 1.60 (1.27–2.02) < 0.001
Model 2 1 1.13 (0.90–1.43) 1.20 (0.94–1.52) 1.39 (1.10–1.75) 0.005
Serum Zn (μmol/L) 8.26–13.15 13.16–14.22 14.23–15.30 15.31–24.78
N of events/subjects 177/493 (35.9%) 141/499 (28.3%) 161/493 (32.7%) 157/490 (32.0%)
IR/1000 PY 20.2 14.4 16.3 16.2
Model 1 1 0.68 (0.54–0.85) 0.80 (0.65–1.00) 0.85 (0.69–1.06) 0.307
Model 2 1 0.71 (0.57–0.89) 0.84 (0.67–1.04) 0.83 (0.67–1.04) 0.218
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its role in iron mobilization and homeostasis and be the 
consequence of iron sequestration from microbes [38]. One 
potential explanation for the association between serum Cu 
concentration and infection incidence could thus be reverse 
causality. However, this may not be a likely explanation, 
because excluding the incident infections that occurred dur-
ing the first 2 years of follow-up did not affect the associa-
tions with Cu.
The serum Zn concentration is typically decreased 
in infections [39]. This may be due to Zn deficiency [6], 
defined as a serum Zn concentration below 10.7 μmol/L 
[40], or due to the nutritional immunity [41], as serum Zn is 
redistributed through activation of inflammatory cytokines 
in particular into the liver [7, 42]. Furthermore, a decrease 
of serum Zn concentration and consequently an increase of 
Cu/Zn-ratio have been observed with advancing age [17]. It 
has been claimed that free-living elderly are prone to mild 
Zn deficiency [5, 18]. This may be linked to several factors 
associated with ageing, such as insufficient dietary Zn intake 
(e.g. problems of mastication leading to avoidance of Zn-
rich foods like red meat), reduced intestinal absorption or 
increased losses (diarrhea, diuretics) [18]. However, in our 
study there were no major differences in dietary intakes 
across quartiles of serum Cu/Zn-ratio, including Zn intake 
(Table 1), suggesting that poor nutritional status is not a 
likely explanation for our findings. Neither did adjustment 
for serum albumin as a possible marker for poor nutritional 
status have any impact on the risk of an incident infection. 
Also a mild Zn deficiency has an adverse influence on the 
immune system. Similar alterations in immune system seen 
in Zn deficiency and immunosenescence suggest that these 
might be related phenomena [5, 18]. Additionally, a chronic 
exposure to cadmium can lead to a reduced renal reabsorp-
tion of Zn and result in decreased serum Zn concentration 
and increased Cu/Zn-ratio notably in smokers [19]. How-
ever, in our analyses Zn concentration was not associated 
Fig. 1  Hazard ratios of the serum copper-to-zinc-ratio and serum 
copper and serum zinc with risk of an incident infection among 1975 
men, evaluated by restricted cubic splines from Cox proportional haz-
ards models. The model is adjusted for age (years), examination year, 
history of coronary heart disease, stroke, cancer or diabetes (yes/
no); smoking (never smoker, previous smoker, current smoker < 20 
cigarettes/day, current smoker > 20 cigarettes/day); education (years); 
income (euros/year); intake of alcohol (g/week); leisure-time physical 
activity (kcal/day); and body mass index. The solid line represents the 
central risk estimate and the shaded area the 95% confidence inter-
val. The dotted vertical lines correspond to 10th, 25th, 50th, 75th and 
90th percentile of the serum copper-to-zinc-ratio or serum copper or 
zinc concentrations
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with higher risk of an infection among the smokers, either. 
In this study we found an inverse association between 
serum Zn concentrations and risk of an infection with the 
shorter, 10-year follow-up, although without evidence for 
dose–response. This might be due to the attenuation of the 
relation during the longer follow-up time. Another poten-
tial explanation could be the small proportion of subjects 
(1.7%), which had serum Zn concentration lower than 10.7 
μmol/L defined as Zn deficiency [40] and that higher Zn 
concentrations seem not to lower the risk of incident infec-
tions. The amount of Zn deficient subjects is less than the 
proportions reported in other studies varying from 3 to 4.8% 
in free-living elderly populations in Europe [40]. In the cur-
rent work the mean serum Zn concentration (14.4 μmol/L) 
is in the same range as Zn values for men reported in other 
studies, such as in the ZENITH study [40], NHANES II 
Study (1976–1980) [43], and AREDS study [44]. There is 
no clear explanation for our finding that higher serum Zn 
concentration was associated with a lower risk among men 
with higher BMI, but because of the many interaction analy-
ses, this could also be a chance finding.
The strengths of the current study are the long follow-up 
with a large number and detailed information of incident 
infections, population-based recruitment, and extensive 
examinations for potential confounders. The potential weak-
ness is the single measurement of serum Cu and Zn concen-
trations at baseline, which may attenuate the associations 
during a long follow-up. This is supported by the stronger 
associations in the analyses with a shorter follow-up. As 
the study population included only middle-aged and older 
men from Eastern Finland, generalization to other popula-
tions should be done with caution. This includes potential 
gender-specific differences. In the present study the most 
common infection was pneumonia. It has been observed that 
the incidence of pneumonia in Europe is higher in men than 
in women [45]. In general, urinary tract infections (UTI) 
are the most common infections of the elderly [46]. Tak-
ing into account that the prevalence ratio of UTI between 
older women and men is 2:1 [47], it is conceivable that the 
incidence of UTI would be higher if women were included 
in the study population. Furthermore, it has been shown that 
gender differences exist in metal blood concentrations: Cu 
concentration is significantly higher in elderly women, while 
Zn concentration is higher in elderly men [48].
In conclusion, our data suggest that a higher serum Cu/
Zn-ratio is associated with increased risk of incident infec-
tion in middle-aged and older men. However, because serum 
Cu concentration had a stronger association with increased 
risk, this suggests that serum Cu concentration alone could 
be a better marker for future risk of an infection. Further 
research in other study populations is required to verify the 
results.
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